TTK Healthcare Limited has informed the Exchange about General Updates
TTKHLTCARE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
TTK Healthcare has submitted its Business Responsibility and Sustainability Report (BRSR) for FY 2024-25 to BSE and NSE, as mandated under SEBI LODR Regulation 34(2)(f). The BRSR forms part of the company's Annual Report for the same year. Key financials disclosed: standalone turnover of Rs. 801.49 crore and net worth of Rs. 1,042.57 crore. The company operates across 7 product categories, with Male Contraceptives (25.78%), Food Products (16.60%), and Animal Welfare Products (15.77%) being the largest revenue contributors, and exports to 54 countries (10.66% of turnover). The report flags 12 material ESG issues, with the company identifying Occupational Health & Safety, Cost Pressures, Geopolitics, and Regulatory Compliance as key risks. The company also disclosed paying a Rs. 2.70 lakh SOP fine each to BSE and NSE for delayed compliance with board composition norms, against which an appeal has been filed.
This is a routine annual regulatory filing rather than a price-moving event. Investors should note the reported one worker fatality and 22 work-related injuries in FY25 as a safety concern, while the expanded dealer network (6,393, up from 5,656) and higher wellbeing spending (0.88% of revenue) are positive operational signals. The BRSR has not been independently assured.